Home > Investor

Investor

Share Trends
Stock Performance
Warsaw Stock Exchange
Bulgarian Stock Exchange
Corporate News
28 October 2021
The Executive Director of Sopharma met with Vice President of Vietnam Mrs. Vo Thi Anh Xuan
Financial News
20 March 2023
Sales revenues for February 2023
21 February 2023
Notification for share participation from “Telso” AD
21 February 2023
Notification for share participation from “Donev investments holding” AD
Financial Highlights 31 March, 2022
397 570
BGN '000 Revenue
34 368
BGN '000 EBITDA
21 827
BGN '000 Revenue from operating profit
22 560
BGN '000 Net profit for the year
0.17
BGN Earnings per share

Next events
31 March 2023
Publication of the Annual Individual Audit Report for 2022
20 April 2023
Financial revenues for January-March 2023

Equity story

85+ year track record in the pharma industry

  • Leadership
  • Growth
  • Portfolio
  • Profitability
  • Business Model
  • M&A